Microbot Medical Inc  

(Public, NASDAQ:MBOT)   Watch this stock  
Find more results for NASDAQ:STEM
+0.06 (1.96%)
After Hours: 3.10 -0.02 (-0.64%)
May 25, 4:07PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 3.01 - 3.15
52 week 2.97 - 27.45
Open 3.06
Vol / Avg. 57,460.00/52,702.00
Mkt cap 88.95M
P/E     -
Div/yield     -
EPS -0.71
Shares 27.95M
Beta 0.05
Inst. own 11%

Key stats and ratios

Q1 (Mar '17) 2016
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -115.92% -495.92%
Return on average equity -159.22% -945.04%
Employees 6 -
CDP Score - -


175 Derby St # 27/1
HINGHAM, MA 02043-4007
United States - Map
+1-908-9385561 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Microbot Medical Inc., formerly StemCells, Inc., is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures. Its ViRob technology is an autonomous crawling micro-robot, which can be controlled remotely or within the body. The Microbot SCS device is a robotic system designed as the ventricular catheter portion of a cerebrospinal fluid (CSF) shunt system. The Company's TipCAT is an endoscope that provides see and treat capabilities within tubular lumens in the human body, such as the colon, blood vessels and the urinary tract.

Officers and directors

Harel Gadot Chairman of the Board, President, Chief Executive Officer
Bio & Compensation  - Reuters
David Ben Naim Chief Financial Officer
Age: 48
Bio & Compensation  - Reuters
Yehezkel Himelfarb Chief Operating Officer, General Manager - Israeli Operations
Age: 59
Bio & Compensation  - Reuters
Yoseph Bornstein Director
Bio & Compensation  - Reuters
Scott R. Burell Director
Age: 51
Bio & Compensation  - Reuters
Solomon Mayer Director
Age: 62
Bio & Compensation  - Reuters
Moshe Shoham Director
Age: 65
Bio & Compensation  - Reuters
Yoav Zvi Waizer Director
Bio & Compensation  - Reuters